(Q40743022)

23 September 2017

1 reference

title

Influence of drug formulation on drug concentration-effect relationships (English)

1 reference

23 September 2017

author name string

G Castañeda-Hernández

series ordinal

1

1 reference

23 September 2017

G Caillé

series ordinal

2

1 reference

23 September 2017

P du Souich

series ordinal

3

1 reference

23 September 2017

publication date

1 February 1994

1 reference

Clinical Pharmacokinetics

23 September 2017

published in

1 reference

23 September 2017

volume

26

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

135-143

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199426020-00006

23 September 2017

exact match

0 references

cites work

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

12 December 2020

Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders

1 reference

12 December 2020

A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products

1 reference

12 December 2020

Nifedipine: kinetics and dynamics in healthy subjects

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulation

1 reference

12 December 2020

Pharmacokinetic determinants of nitrate action

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

1 reference

12 December 2020

Multi-centre general practitioner comparative study of controlled-release ('Valrelease') and conventional ('Valium') forms of diazepam in patients suffering from anxiety

1 reference

12 December 2020

On the mechanism of acute tolerance to furosemide diuresis

1 reference

12 December 2020

Rate-controlled drug delivery

1 reference

12 December 2020

Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms

1 reference

12 December 2020

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man

1 reference

12 December 2020

Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

1 reference

12 December 2020

Therapeutic monitoring of theophylline. Rationale and current status

1 reference

12 December 2020

The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.

1 reference

12 December 2020

Plasma concentration-response relationships for some cardiovascular effects of dihydropyridines in healthy subjects.

1 reference

12 December 2020

Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

1 reference

12 December 2020

Acute and subacute effects of diazepam on human performance: comparison of plain tablet and controlled release capsule.

1 reference

12 December 2020

Comparison of controlled-release diazepam capsules and placebo in patients in general practice.

1 reference

12 December 2020

Pharmacokinetic/dynamic correlation of pulmonary and cardiac effects of fenoterol in asthmatic patients after different routes of administration.

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects

1 reference

12 December 2020

Resistance to loop diuretics. Why it happens and what to do about it.

1 reference

12 December 2020

Determinants of response to frusemide in normal subjects

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol

1 reference

12 December 2020

Renal tubular secretion and effects of furosemide

1 reference

12 December 2020

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders

1 reference

12 December 2020

Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy

1 reference

12 December 2020

Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect

1 reference

12 December 2020

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers

1 reference

12 December 2020

Relationship between plasma prazosin concentration and alpha-antagonism in humans: comparison of conventional and rate-controlled (Oros) formulations

1 reference

12 December 2020

Nifedipine. Relationship between pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients

1 reference

12 December 2020

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies

1 reference

12 December 2020

Drug absorption rate: a critical component of bioequivalence assessment in psychopharmacology

1 reference

12 December 2020

Scientific rationale and clinical implications of sustained-release formulations

1 reference

12 December 2020

Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects.

1 reference

12 December 2020

Kinetics and dynamics of furosemide and slow-acting furosemide

1 reference

12 December 2020

10.2165/00003088-199426020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

1013152376

0 references

1 reference